High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activitySohyon Lee, Berend Snijder, Elisabeth J. Rushing et al.|Nature Medicine|2024Cited by 68
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma ProgressionJoão Conde, Gonçalo J. L. Bernardes, Charlotte Baker et al.|ACS Central Science|2021Cited by 63
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myelomaKlara Kropivšek, Berend Snijder, Paul Kachel et al.|Nature Cancer|2023Cited by 42
A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programsSarah Cherkaoui, Nicola Zamboni, Stephan Durot et al.|Molecular Systems Biology|2022Cited by 36
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M. Eichhoff, Mitchell P. Levesque, Corinne I. Stoffel et al.|Cancer Research|2023Cited by 24